IFNB1 and neoplasm: Theoretically, even if only some MSCs express IFN-β, ASC-IFN-β is expected to compensate for the lower transfection efficiency of MSCs in expressing TRAIL and increasing local TRAIL expression compared to that with ASC-TRAIL because IFN-β can induce TRAIL expression in the surrounding MSCs or tumor cells.